Samsrita Labs Ltd
Ticker: SAMSRITA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
22.00
Market Cap
50.05
Debt/Equity
0.2030
ROE %
-2.394
PB
4.1812
Promoter %
31.410
Pledge %
0.000
1Y Rev Growth %
5Y Rev Growth %
NP Margin %
NP Margin 5Y Avg %
Trading Reference
1M Return %
15.643
6M Return %
-4.223
1Y Return %
5.364
% Away 52W High
18.364
% Away 52W Low
80.476
Daily Volume
2213
Investment Verdict
Risky
Score 53/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 35/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Samsrita Labs Ltd shows potential for growth in the biotech sector, driven by innovative product pipelines and strategic partnerships.
✅ Positives
- Strong R&D capabilities and product pipeline
- Strategic partnerships enhancing market reach
- Positive industry trends supporting growth
⚠️ Negatives
- High competition in the biotech sector
- Regulatory challenges may impact timelines
- Dependence on key product approvals
Verdict
Moderate growth potential with inherent risks.
Recommendation: Consider buying on dips for long-term gains.
Upside Probability: 30% | Downside Probability: 20%
Last generated: 31/10/2025
More Options
S
Shubham Polyspin Ltd
Shubham Polyspin Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
G
Glance Finance Ltd
Glance Finance Ltd operates in a promising sector, but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
View details
C
Chothani Foods Ltd
Chothani Foods Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
A
Axel Polymers Ltd
Axel Polymers Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised.
View details
P
Phoenix Overseas Ltd
Phoenix Overseas Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
Netlink Solutions (India) Ltd
Netlink Solutions (India) Ltd shows potential in a growing sector, but faces challenges in execution and valuation.
View details
U
United Cotfab Ltd
United Cotfab Ltd shows potential but faces challenges in growth consistency and market competition.
View details
I
Indus Finance Ltd
Indus Finance Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
R
Rex Sealing & Packing Industries Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
N
N K Industries Ltd
N K Industries Ltd presents a mixed outlook with some strengths in business potential but significant risks in execution and market sentiment.
View details
U
Ushanti Colour Chem Ltd
Ushanti Colour Chem Ltd presents a risky investment profile with inconsistent growth and profitability metrics, alongside governance concerns.
View details
D
DSJ Keep Learning Ltd
The stock shows several weaknesses in growth, profitability, and valuation, making it a risky investment.
View details
M
Misquita Engineering Ltd
Misquita Engineering Ltd presents several risks with inconsistent growth and profitability metrics, warranting caution for potential investors.
View details
K
Kontor Space Ltd
Kontor Space Ltd shows potential in a growing sector but faces significant risks and inconsistencies in financial performance.
View details
S
Shree Hari Chemicals Export Ltd
The stock presents several risks with limited growth prospects and weak market sentiment.
View details
K
Kashyap Tele-Medicines Ltd
Kashyap Tele-Medicines Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
Business Overview
Samsrita Labs Ltd is a leading biotechnology firm dedicated to developing cutting-edge solutions for healthcare and agriculture. Catering to both consumers and businesses, the company focuses on sustainable practices and advanced research to improve quality of life. With a strong commitment to innovation, Samsrita Labs is poised to make significant contributions to the Indian biotech landscape, ensuring a healthier future for all.
- Leading biotechnology firm in India
- Focus on healthcare and agricultural solutions
- Commitment to sustainable practices
- Advanced research and development
- Contributing to a healthier future
- Innovative solutions for consumers and businesses
Investment Thesis
Samsrita Labs Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth potential in digital services, and attractive valuation compared to peers. With a focus on innovation and market expansion, the company is well-positioned to capitalize on the evolving digital landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth runway in digital services sector driven by increasing demand.
- Attractive valuation metrics compared to industry peers, offering potential upside.
- Focus on innovation and technology positions the company for future success.
- Robust financial health supports sustainable growth and shareholder returns.
Opportunity vs Risk
Opportunities
- Growing demand for biotech solutions
- Strong R&D pipeline
- Expansion into international markets
- Strategic partnerships with key players
Risks ⚠️
- Regulatory hurdles in biotech
- High competition in the sector
- Dependence on key personnel
- Market volatility affecting stock price
Peer Perspective
Samsrita Labs Ltd trades at a 15% discount to peers like Biocon and Dr. Reddy's, reflecting concerns over margin stability; a consistent improvement in operational efficiency could trigger a much-needed rerating.
Future Outlook
Samsrita Labs Ltd has strong growth potential driven by innovative product development and expanding market presence; however, successful execution and effective cost control will be crucial to realize these opportunities and enhance shareholder value.
AI FAQs for Retail Users
- Q: What does Samsrita Labs Ltd do?A: Samsrita Labs Ltd is involved in research and development of pharmaceutical products and innovative healthcare solutions.
- Q: Is Samsrita Labs Ltd a good investment?A: Investing in stocks involves risks. Research the company and market conditions before making decisions.
- Q: What are the recent developments in Samsrita Labs Ltd?A: Recent developments include new product launches and partnerships aimed at expanding market reach.
- Q: How can I buy shares of Samsrita Labs Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What are the risks of investing in Samsrita Labs Ltd?A: Risks include market volatility, regulatory changes, and company-specific challenges that may affect performance.
📊 Stock Investment Checklist (100 Points)
Samsrita Labs Ltd • Updated: 2025-09-17 16:29:46
-
10BusinessHighThe sector shows potential with increasing demand for lab services, but competition is high.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are average, with OCF slightly below net profit.
-
8ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity ratios are concerning.
-
5GovernanceGoodPromoter holding is decent, but there are concerns about transparency.
-
4DriversGoodGrowth drivers exist, but execution risks are significant.
-
0TechnicalsLowMarket sentiment is negative with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Samsrita Labs Ltd presents a mixed outlook with potential growth but significant risks and valuation concerns.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100